Literature DB >> 9129476

Effect of dietary calcium on urinary oxalate excretion after oxalate loads.

M Liebman1, W Chai.   

Abstract

An experimental model that allowed differentiation between endogenously and exogenously derived urinary oxalate was used to assess the effect of different forms and doses of ingested calcium on oxalate absorption and excretion. In replication 1 (R-1), subjects participated in three oxalate load (OL) tests: baseline (OL alone), calcium carbonate (OL with concomitant calcium carbonate ingestion), and calcium citrate malate (CCM) (OL with concomitant CCM ingestion). The calcium salts each provided 300 mg elemental Ca. OLs consisted of 180 mg unlabeled and 18 mg 1,2[13C2]oxalic acid. In R-2, subjects participated in four OL tests: baseline (OL alone) and OLs administered concomitantly with 100, 200, or 300 mg Ca. Timed urine samples after the OL were collected at 2-h intervals for the initial 6 h and samples were pooled into 9-h aliquots for the remaining 18 h of the 24-h period. In R-1, 24-h mean exogenous oxalate decreased (P < 0.05) after the OL from 36.2 mg (baseline) to 16.1 mg (after calcium carbonate) and to 14.3 mg (after CCM) whereas endogenous oxalate remained relatively constant. Mean 24-h oxalate absorption decreased significantly from that at the time of the baseline treatment (18.3%) after both calcium carbonate (8.1%) and CCM (7.2%) treatments. In R-2, mean 24-h oxalate absorption was significantly lower after 200 (5.9%) and 300 (7.6%) mg Ca than after 100 mg Ca (9.1%) and the OL alone (11.3%). Concomitant meal ingestion significantly decreased oxalate absorption in the absence of dietary calcium but not in association with the 300-mg Ca treatment. The overall data provide definitive evidence that dietary calcium can reduce oxalate absorption and excretion. Calcium carbonate and CCM were equally effective in this regard and a minimum of 200 mg elemental Ca maximized this effect in conjunction with an oxalic acid intake of 198 mg.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129476     DOI: 10.1093/ajcn/65.5.1453

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  19 in total

1.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  The impact of dietary oxalate on kidney stone formation.

Authors:  Ross P Holmes; Dean G Assimos
Journal:  Urol Res       Date:  2004-06-17

Review 3.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

4.  Influence of a high-oxalate diet on intestinal oxalate absorption.

Authors:  Diana J Zimmermann; Albrecht Hesse; Gerd E von Unruh
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

5.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

6.  Problems in the metabolic evaluation of renal stone disease: audit of intra-individual variation in urine metabolites.

Authors:  Pallavoor S Anandaram; Alan R De Bolla; Peter R Hudson; Gareth K Davies; Purnendu Majumdar; Clive P Williams
Journal:  Urol Res       Date:  2006-05-06

7.  Oxalate nephropathy from cashew nut intake.

Authors:  Margarida Bernardino; Malvinder S Parmar
Journal:  CMAJ       Date:  2016-12-12       Impact factor: 8.262

Review 8.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 9.  Probiotics and other key determinants of dietary oxalate absorption.

Authors:  Michael Liebman; Ismail A Al-Wahsh
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

Review 10.  The management of patients with enteric hyperoxaluria.

Authors:  John R Asplin
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.